Thymosin α1: a novel therapeutic option
Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
✍
Virgil Dalm, Rochus Neeleman, Harm de Wit…
📂
Article
📅
2013
🏛
BioMed Central
🌐
English
⚖ 78 KB